PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34677731-7 2021 Eugenol also reduced SARS-CoV-2 spike S1-induced activation of NF-kappaB and the expression of IL-6, IL-1beta and TNFalpha in human A549 lung cells. Eugenol 0-7 nuclear factor kappa B subunit 1 Homo sapiens 63-72 28915591-7 2017 Furthermore eugenol for external (1 mg) markedly decreased the protein expressions of HER2 (62.9%), AKT (58.6%), PDK1 (56.4%), p85 (54.3%), Bcl2 (59.3%), NF-kappaB (65.7%), Bad (64.0%), Cyclin D1 (43.0%), while p21, p27 and Bax protein expressions were respectively increased 1.83-, 2.52- and 2.51-fold. Eugenol 12-19 nuclear factor kappa B subunit 1 Homo sapiens 154-163 17889685-0 2007 Eugenol modulates cyclooxygenase-2 expression through the activation of nuclear factor kappa B in human osteoblasts. Eugenol 0-7 nuclear factor kappa B subunit 1 Homo sapiens 72-94 17889685-2 2007 In this study, the effects of eugenol on the activation of nuclear factor kappa B (NF-kappaB) and the expression of cyclooxygenase-2 (COX-2) in human osteoblasts were investigated. Eugenol 30-37 nuclear factor kappa B subunit 1 Homo sapiens 59-81 17889685-2 2007 In this study, the effects of eugenol on the activation of nuclear factor kappa B (NF-kappaB) and the expression of cyclooxygenase-2 (COX-2) in human osteoblasts were investigated. Eugenol 30-37 nuclear factor kappa B subunit 1 Homo sapiens 83-92 17889685-3 2007 The results showed that eugenol activated the nuclear translocation of NF-kappaB. Eugenol 24-31 nuclear factor kappa B subunit 1 Homo sapiens 71-80 35504091-0 2022 Eugenol suppresses the proliferation and invasion of TNF-alpha-induced fibroblast-like synoviocytes via regulating NF-kappaB and COX-2. Eugenol 0-7 nuclear factor kappa B subunit 1 Homo sapiens 115-124 35504091-5 2022 Eugenol"s target genes were significantly associated with vascular endothelial growth factor (VEGF) and NF-kappaB (NF-kappaB) signaling pathway. Eugenol 0-7 nuclear factor kappa B subunit 1 Homo sapiens 104-113 35504091-5 2022 Eugenol"s target genes were significantly associated with vascular endothelial growth factor (VEGF) and NF-kappaB (NF-kappaB) signaling pathway. Eugenol 0-7 nuclear factor kappa B subunit 1 Homo sapiens 115-124 35504091-6 2022 Eugenol reversed the promoting effect of TNF-alpha on the expression of NF-kappaB signaling pathway-related proteins as well as prostaglandin-endoperoxide synthase 2 (PTGS2, also known as COX-2) protein. Eugenol 0-7 nuclear factor kappa B subunit 1 Homo sapiens 72-81 35504091-8 2022 In conclusion, eugenol may represent a novel drug to suppress the progression of RA by inhibiting NF-kappaB signaling pathway and COX-2 expression in fibroblast-like synovial cells. Eugenol 15-22 nuclear factor kappa B subunit 1 Homo sapiens 98-107 30932261-0 2019 Eugenol inhibits non-small cell lung cancer by repressing expression of NF-kappaB-regulated TRIM59. Eugenol 0-7 nuclear factor kappa B subunit 1 Homo sapiens 72-81 30932261-12 2019 Eugenol inhibited NSCLC via repression NF-kappaB-TRIM59 pathway. Eugenol 0-7 nuclear factor kappa B subunit 1 Homo sapiens 39-48 17889685-5 2007 Furthermore, the eugenol-modulated COX-2 expression was inhibited by an NF-kappaB inhibitor, N-acetylcysteine. Eugenol 17-24 nuclear factor kappa B subunit 1 Homo sapiens 72-81 17889685-6 2007 Taken together, eugenol might induce COX-2 expression through the activation of NF-kappaB in human osteoblasts. Eugenol 16-23 nuclear factor kappa B subunit 1 Homo sapiens 80-89